Cytokinetics, Incorporated · NASDAQ:CYTK

Wierenga Wendell received 2,851 Cytokinetics, Incorporated shares as an award (Form 4)

Traded May 27, 2026 · Filed May 27, 2026

On May 27, 2026, Wierenga Wendell (Director) received 2,851 Cytokinetics, Incorporated shares as an award, leaving 35,488 shares. Filed May 27, 2026 (Form 4).

Awarded
2,851 shares
Holding after
35,488 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockAward2,85135,488Direct

Source

View original at SEC

Related